# A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy Participants

> **NCT03952507** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-64417184 600 (Oral Tablet Formulation)
- **DRUG:** JNJ-64417184 (Oral Suspension Formulation)

## Key facts

- **NCT ID:** NCT03952507
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-15
- **Primary completion:** 2019-06-22
- **Final completion:** 2019-06-22
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03952507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03952507, "A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03952507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*